Placental growth factor (PlGF) is a proangiogenic member of the vascular endothelial growth
factor (VEGF) family playing a central role in pathological angiogenesis. PlGF-DE is a PlGF …

The placental growth factor (PlGF) is an angiogenic protein belonging to the vascular
endothelial growth factor (VEGF) family, which was discovered in 1991 by an Italian …

Many proliferative diseases, most typically cancer, are driven by uncontrolled blood vessel
growth. Genetic studies have been very helpful in unraveling the cellular and molecular …

An agent that blocks tumor angiogenesis, growth, and metastasis without affecting normal
tissues—whether used alone or in combination with currently approved drugs—would …

Placental growth factor (PlGF) belongs to the same family as the vascular endothelial growth
factor A (VEGF-A). Recent gene inactivation studies in mice have demonstrated that loss of …

Vascular endothelial growth factor (VEGF) is a potent mitogen for endothelial cells in vitro,
promotes neoangiogenesis in vivo and increases the permeability of the vascular …

Angiogenesis is one of the crucial events for cancer development and growth and vascular
endothelial growth factor (VEGF) family plays an essential role in this biological …

Efforts to therapeutically stimulate or inhibit vessel growth have been primarily focused on
vascular endothelial growth factor (VEGF) and its receptor VEGFR‐2 (Flk‐1), while little …

Vascular endothelial growth factor (VEGF) stimulates angiogenesis by activating VEGF
receptor-2 (VEGFR-2). The role of its homolog, placental growth factor (PlGF), remains …

Tumor angiogenesis is essential for solid tumor growth. The object of this study was to
investigate the presence of newly identified angiogenic factor, placenta growth factor (P1GF) …